Drug Approval | December 06, 2023
Zydus receives final approval from the USFDA for Ivabradine Tablets
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
Clindamycin Phosphate Gel is used to treat acne
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
The programme was conducted as a part of MPMCx, an exclusive management programme for MBBS doctors by IIM-Ahmedabad in collaboration with DailyRounds
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The group now has 372 approvals and has so far filed over 442* ANDAs since the commencement of the filing process in FY 2003-04.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
